Crystal Pharmatech is heading to BioTechX USA 2025!
We're excited to join our partner biosimulytics at Booth S5 on September 16-17 in Philadelphia.
Come meet our Co-founder & CBO, Dr. Robert Wenslow, and Subject Matter Expert, Derik McCarthy, as we showcase how integrated in silico prediction + experimental CMC strategy can accelerate small molecule development.
With Peter F Doyle (CEO, Co-Founder & Board Member) and Johannes Eiglsperger (CTO) of Biosimulytics also attending, we'll dive into how:
AI-powered solid-state prediction enables smarter form selection
API-sparing workflows reduce IND risk by improving solubility and PK early
Collaborative platforms can de-risk formulation and accelerate decision-making
Attendee:
Robert Wenslow, Ph.D.
Co-founder and CBO
Crystal Pharmatech
Derik McCarthy
Subject Matter Expert
Crystal Pharmatech
Subscribe to be the first to get the updates!
